Preexisting memory CD4+ T cells contribute to the primary response in an HIV-1 vaccine trial

Suzanne L Campion, Elena Brenna, Elaine Thomson, Will Fischer, Kristin Ladell, James E McLaren, David A Price, Nicole Frahm, Juliana M McElrath, Kristen W Cohen, Janine R Maenza, Stephen R Walsh, Lindsey R Baden, Barton F Haynes, Bette Korber, Persephone Borrow, Andrew J McMichael, Suzanne L Campion, Elena Brenna, Elaine Thomson, Will Fischer, Kristin Ladell, James E McLaren, David A Price, Nicole Frahm, Juliana M McElrath, Kristen W Cohen, Janine R Maenza, Stephen R Walsh, Lindsey R Baden, Barton F Haynes, Bette Korber, Persephone Borrow, Andrew J McMichael

Abstract

Naive and memory CD4+ T cells reactive with human immunodeficiency virus type 1 (HIV-1) are detectable in unexposed, unimmunized individuals. The contribution of preexisting CD4+ T cells to a primary immune response was investigated in 20 HIV-1-seronegative volunteers vaccinated with an HIV-1 envelope (Env) plasmid DNA prime and recombinant modified vaccinia virus Ankara (MVA) boost in the HVTN 106 vaccine trial (clinicaltrials.gov NCT02296541). Prevaccination naive or memory CD4+ T cell responses directed against peptide epitopes in Env were identified in 14 individuals. After priming with DNA, 40% (8/20) of the elicited responses matched epitopes detected in the corresponding preimmunization memory repertoires, and clonotypes were shared before and after vaccination in 2 representative volunteers. In contrast, there were no shared epitope specificities between the preimmunization memory compartment and responses detected after boosting with recombinant MVA expressing a heterologous Env. Preexisting memory CD4+ T cells therefore shape the early immune response to vaccination with a previously unencountered HIV-1 antigen.

Keywords: Cellular immune response; Clinical Trials; Immunology; T cells.

Figures

Figure 1. The preimmunization repertoire of Env-specific…
Figure 1. The preimmunization repertoire of Env-specific memory CD4+ T cells.
Preimmunization repertoires of 20 donors were screened for Env reactivity using the T cell library method with 2 pools of overlapping peptides collectively spanning the entire consensus sequence protein (ConS). Positive control wells included phytohemagglutinin (PHA) and IL-2. Proliferative responses are shown for memory CD4+ T cells isolated from all 20 volunteers before vaccination (V2). Data are shown after background subtraction (mean ± SD). Positive responses were defined as greater than 3,000 cpm, with a stimulation index greater than 5 (dotted line).
Figure 2. Precursor frequency and epitope specificity…
Figure 2. Precursor frequency and epitope specificity of preimmunization Env-reactive naive and memory CD4+ T cells.
Env-reactive CD4+ T cell lines derived from the preimmunization naive and memory repertoires of 20 donors were mapped for epitope specificity. Precursor frequencies were calculated from the initial limiting dilution. (A) Naive and memory precursor frequencies for each specificity. Each symbol represents one CD4+ T cell line. Bars show mean values. (B) Epitope specificities and precursor frequencies determined for memory CD4+ T cells.
Figure 3. Epitope specificity of preimmunization and…
Figure 3. Epitope specificity of preimmunization and postvaccination Env-reactive CD4+ T cells.
Postvaccination CD4+ T cell responses were mapped and quantified at V7 using ex vivo and cultured IFN-γ ELISpot assays. (A) Heatmaps showing the combined epitope mapping data from all volunteers at V7 (left) alongside a comparison with the epitope mapping data from all 20 volunteers at V2 (right). Ex vivo results are shown if both ex vivo and cultured data were available. Mean values are shown. SFU, spot-forming unit. (B) Identification of matching epitope-specific responses in the preimmunization and postvaccination repertoires of 4 donors immunized with ConS DNA. The scale for ex vivo and cultured data is shown on the left y axis, and the scale for naive (yellow) or memory (orange) precursor frequencies is shown on the right y axis. Mean ± SEM.
Figure 4. Clonotype representation in the preimmunization…
Figure 4. Clonotype representation in the preimmunization and postvaccination repertoires of Env-reactive CD4+ T cells.
(A) CD4+ T cell clones were derived from preimmunization repertoires (V2) of 2 volunteers, 106-009 and 106-039, who showed matching postvaccination responses to ConS peptides (V7). Expressed TRA and TRB gene rearrangements were sequenced from mRNA. (B) Protein-level expression of the corresponding TCR Vβ segments at each time point determined by flow cytometry. Plots are gated on live CD3+ cells. (C) The postvaccination TCR Vβ–defined populations shown in B were isolated by FACS to purity. Expressed TRB gene rearrangements were sequenced from mRNA. Each pie chart segment represents a distinct clonotype and the matching clonotype sequences from A.

References

    1. Mason D. A very high level of crossreactivity is an essential feature of the T-cell receptor. Immunol Today. 1998;19(9):395–404. doi: 10.1016/S0167-5699(98)01299-7.
    1. Chen W, et al. Dissecting the multifactorial causes of immunodominance in class I-restricted T cell responses to viruses. Immunity. 2000;12(1):83–93. doi: 10.1016/S1074-7613(00)80161-2.
    1. McHeyzer-Williams LJ, et al. Evolution of antigen-specific T cell receptors in vivo: preimmune and antigen-driven selection of preferred complementarity-determining region 3 (CDR3) motifs. J Exp Med. 1999;189(11):1823–1838. doi: 10.1084/jem.189.11.1823.
    1. McHeyzer-Williams MG, Davis MM. Antigen-specific development of primary and memory T cells in vivo. Science. 1995;268(5207):106–111. doi: 10.1126/science.7535476.
    1. Kaufmann DE, et al. Comprehensive analysis of human immunodeficiency virus type 1-specific CD4 responses reveals marked immunodominance of gag and nef and the presence of broadly recognized peptides. J Virol. 2004;78(9):4463–4477. doi: 10.1128/JVI.78.9.4463-4477.2004.
    1. Kim A, Sadegh-Nasseri S. Determinants of immunodominance for CD4 T cells. Curr Opin Immunol. 2015;34:9–15. doi: 10.1016/j.coi.2014.12.005.
    1. Su LF, Davis MM. Antiviral memory phenotype T cells in unexposed adults. Immunol Rev. 2013;255(1):95–109. doi: 10.1111/imr.12095.
    1. Campion SL, et al. Proteome-wide analysis of HIV-specific naive and memory CD4(+) T cells in unexposed blood donors. J Exp Med. 2014;211(7):1273–1280. doi: 10.1084/jem.20130555.
    1. Mateus J, et al. Selective and cross-reactive SARS-CoV-2 T cell epitopes in unexposed humans. Science. 2020;370(6512):89–94. doi: 10.1126/science.abd3871.
    1. Su LF, et al. Virus-specific CD4(+) memory-phenotype T cells are abundant in unexposed adults. Immunity. 2013;38(2):373–383. doi: 10.1016/j.immuni.2012.10.021.
    1. Mason D. Some quantitative aspects of T-cell repertoire selection: the requirement for regulatory T cells. Immunol Rev. 2001;182:80–88. doi: 10.1034/j.1600-065X.2001.1820106.x.
    1. Nikolich-Žugich J, et al. The many important facets of T-cell repertoire diversity. Nat Rev Immunol. 2004;4(2):123–132. doi: 10.1038/nri1292.
    1. Birnbaum ME, et al. Deconstructing the peptide-MHC specificity of T cell recognition. Cell. 2014;157(5):1073–1087. doi: 10.1016/j.cell.2014.03.047.
    1. Wooldridge L, et al. A single autoimmune T cell receptor recognizes more than a million different peptides. J Biol Chem. 2012;287(2):1168–1177. doi: 10.1074/jbc.M111.289488.
    1. Fazekas de St Groth, Webster RG. Disquisitions of Original Antigenic Sin. I. Evidence in man. J Exp Med. 1966;124(3):331–345. doi: 10.1084/jem.124.3.331.
    1. Santra S, et al. A centralized gene-based HIV-1 vaccine elicits broad cross-clade cellular immune responses in rhesus monkeys. Proc Natl Acad Sci U S A. 2008;105(30):10489–10494. doi: 10.1073/pnas.0803352105.
    1. Gaschen B, et al. Diversity considerations in HIV-1 vaccine selection. Science. 2002;296(5577):2354–2360. doi: 10.1126/science.1070441.
    1. Goonetilleke N, et al. Induction of multifunctional human immunodeficiency virus type 1 (HIV-1)-specific T cells capable of proliferation in healthy subjects by using a prime-boost regimen of DNA- and modified vaccinia virus Ankara-vectored vaccines expressing HIV-1 Gag coupled to CD8+ T-cell epitopes. J Virol. 2006;80(10):4717–4728. doi: 10.1128/JVI.80.10.4717-4728.2006.
    1. Hladik F, et al. Most highly exposed seronegative men lack HIV-1-specific, IFN-gamma-secreting T cells. J Immunol. 2003;171(5):2671–2683. doi: 10.4049/jimmunol.171.5.2671.
    1. Ritchie AJ, et al. Differences in HIV-specific T cell responses between HIV-exposed and -unexposed HIV-seronegative individuals. J Virol. 2011;85(7):3507–3516. doi: 10.1128/JVI.02444-10.
    1. Geiger R, et al. Human naive and memory CD4+ T cell repertoires specific for naturally processed antigens analyzed using libraries of amplified T cells. J Exp Med. 2009;206(7):1525–1534. doi: 10.1084/jem.20090504.
    1. Boyer JD, et al. Vaccination of seronegative volunteers with a human immunodeficiency virus type 1 env/rev DNA vaccine induces antigen-specific proliferation and lymphocyte production of beta-chemokines. J Infect Dis. 2000;181(2000):476–483.
    1. MacGregor RR, et al. T-cell responses induced in normal volunteers immunized with a DNA-based vaccine containing HIV-1 env and rev. AIDS. 2002;16(16):2137–2143. doi: 10.1097/00002030-200211080-00005.
    1. Mwau M, et al. A human immunodeficiency virus 1 (HIV-1) clade A vaccine in clinical trials: stimulation of HIV-specific T-cell responses by DNA and recombinant modified vaccinia virus Ankara (MVA) vaccines in humans. J Gen Virol. 2004;85(pt 4):911–919.
    1. Ogbe A, et al. T cell assays differentiate clinical and subclinical SARS-CoV-2 infections from cross-reactive antiviral responses. Nat Commun. 2021;12(1):2055. doi: 10.1038/s41467-021-21856-3.
    1. Elias G, et al. Preexisting memory CD4 T cells in naïve individuals confer robust immunity upon vaccination [preprint]. Posted on bioRxiv March 03, 2021.

Source: PubMed

3
구독하다